Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

Vaccine

Volumn 8, Issue 5, 1990, Pages 497-502

  Murphy, Brian R ^a   Sotnikov, Alex V ^b   Lawrence, Lisa A ^a   Banks, Steven M ^a   Prince, Gregory A ^c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

formalin inactivated vaccine; glycoprotein F; pulmonary histopathology; Respiratory syncytial virus

Indexed keywords

FORMALDEHYDE; GLYCOPROTEIN; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; IMMUNIZATION; NONHUMAN; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ANIMAL; ANTIGENS, VIRAL; BRONCHI; COMPARATIVE STUDY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORMALDEHYDE; HESPEROMYINAE; PULMONARY ALVEOLI; RESPIRATORY SYNCYTIAL VIRUSES; RESPIROVIRUS INFECTIONS; TIME FACTORS; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0025052448     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(90)90253-I     Document Type: Article

References (23)

1. Respiratory syncytial virus
2. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial
3. Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies
4. Passive transfer of respiratory syncytial virus (RSV) immune serum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses
5. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity
6. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus
7. Biologic significance of the secretory IgA immunoglobulins
8. Severe illness in children exposed to natural measles after prior vaccination against the disease
9. Altered reactivity to measles virus: atypical measles in children previously immunized with inactivated measles virus vaccine
10. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
11. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection
12. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease
13. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated vaccine
14. The pathogenesis of respiratory syncytial virus infection in cotton rats
15. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function
16. Purification and characterization of the respiratory syncytial virus fusion protein
17. Measurement of protein using bicinchoinic acid
18. 2 test
19. Tables for testing ordered alternatives in an analysis of variance
20. An analysis of variance test for normality (complete samples)
21. Lethal pulmonary disease in respiratory syncytial virus-infected mice following transfer of cytotoxic T cells